Artificial tethering of LC3 or p62 to organelles is not sufficient to trigger autophagy.


Journal

Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092

Informations de publication

Date de publication:
10 10 2019
Historique:
received: 21 06 2019
accepted: 19 09 2019
revised: 12 09 2019
entrez: 12 10 2019
pubmed: 12 10 2019
medline: 28 8 2020
Statut: epublish

Résumé

The retention using selective hooks (RUSH) system allows to retain a target protein fused to green fluorescent protein (GFP) and a streptavidin-binding peptide (SBP) due to the interaction with a molar excess of streptavidin molecules ("hooks") targeted to selected subcellular compartments. Supplementation of biotin competitively disrupts the interaction between the SBP moiety and streptavidin, liberating the chimeric target protein from its hooks, while addition of avidin causes the removal of biotin from the system and reestablishes the interaction. Based on this principle, we engineered two chimeric proteins involved in autophagy, namely microtubule-associated proteins 1A/1B light chain 3B (MAP1LC3B, best known as LC3) and sequestosome-1 (SQSTM1, best known as p62) to move them as SBP-GFP-LC3 and p62-SBP-GFP at will between the cytosol and two different organelles, the endoplasmic reticulum (ER) and the Golgi apparatus. Although both proteins were functional in thus far that SBP-GFP-LC3 and p62-SBP-GFP could recruit their endogenous binding partners, p62 and LC3, respectively, their enforced relocation to the ER or Golgi failed to induce organelle-specific autophagy. Hence, artificial tethering of LC3 or p62 to the surface of the ER and the Golgi is not sufficient to trigger autophagy.

Identifiants

pubmed: 31601788
doi: 10.1038/s41419-019-2011-5
pii: 10.1038/s41419-019-2011-5
pmc: PMC6787181
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
MAP1LC3A protein, human 0
Microtubule-Associated Proteins 0
P62 protein, human 0
RNA-Binding Proteins 0
Recombinant Proteins 0
Green Fluorescent Proteins 147336-22-9
Biotin 6SO6U10H04
Streptavidin 9013-20-1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

771

Références

EMBO J. 2015 Apr 1;34(7):856-80
pubmed: 25712477
Cell Death Differ. 2019 Aug;26(8):1467-1484
pubmed: 30349077
Cell. 2008 Jan 11;132(1):27-42
pubmed: 18191218
Nat Cell Biol. 2018 May;20(5):521-527
pubmed: 29686264
Dev Cell. 2017 Apr 10;41(1):10-22
pubmed: 28399394
FEBS Lett. 2006 May 15;580(11):2623-9
pubmed: 16647067
Autophagy. 2007 Sep-Oct;3(5):413-6
pubmed: 17568180
Nat Rev Drug Discov. 2012 Sep;11(9):709-30
pubmed: 22935804
Autophagy. 2011 Aug;7(8):883-91
pubmed: 21460612
Nat Rev Mol Cell Biol. 2013 Dec;14(12):759-74
pubmed: 24201109
Mol Cell. 2014 Jan 23;53(2):167-78
pubmed: 24462201
J Cell Sci. 2013 Aug 1;126(Pt 15):3237-47
pubmed: 23908376
Nat Rev Mol Cell Biol. 2016 Sep;17(9):537-52
pubmed: 27381245
Cell. 2014 Dec 4;159(6):1263-76
pubmed: 25480292
Cell. 2007 Dec 14;131(6):1149-63
pubmed: 18083104
Sci Rep. 2017 Nov 2;7(1):14915
pubmed: 29097772
Methods Enzymol. 1990;184:51-67
pubmed: 2388586
Trends Cell Biol. 2015 Jun;25(6):354-63
pubmed: 25759175
Nature. 2000 Nov 23;408(6811):488-92
pubmed: 11100732
Autophagy. 2018;14(7):1256-1266
pubmed: 29999454
Nat Methods. 2012 Mar 11;9(5):493-8
pubmed: 22406856
Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):3750-5
pubmed: 11274392
Mol Cell. 2014 Sep 18;55(6):916-930
pubmed: 25175026
J Biol Chem. 2007 Aug 17;282(33):24131-45
pubmed: 17580304
Mol Cell. 2015 Aug 20;59(4):522-39
pubmed: 26295960
J Cell Biol. 2005 Nov 21;171(4):603-14
pubmed: 16286508
Nat Rev Drug Discov. 2017 Jul;16(7):487-511
pubmed: 28529316
Mol Cell Proteomics. 2008 Dec;7(12):2419-28
pubmed: 18687634
Nat Commun. 2013;4:2300
pubmed: 23939249
EMBO J. 2001 Nov 1;20(21):5971-81
pubmed: 11689437
PLoS Biol. 2006 Nov;4(12):e423
pubmed: 17132049
Nature. 2015 Jun 18;522(7556):354-8
pubmed: 26040720
Mol Cell Biol. 2006 Dec;26(24):9220-31
pubmed: 17030611
EMBO J. 2000 Nov 1;19(21):5720-8
pubmed: 11060023
Nature. 2018 Jun;558(7708):136-140
pubmed: 29849149
J Microsc. 1993 Mar;169(3):375-382
pubmed: 33930978

Auteurs

Friedemann Loos (F)

Cell Biology and Metabolomics Platforms, Gustave Roussy Cancer Center, Villejuif, France.
Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France.
Institut National de la Santé et de la Recherche Médicale, UMR1138, Equipe labellisée Ligue Nationale Contre le Cancer, Paris, France.
Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Université Pierre et Marie Curie, Villejuif, France.

Wei Xie (W)

Cell Biology and Metabolomics Platforms, Gustave Roussy Cancer Center, Villejuif, France.
Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France.
Institut National de la Santé et de la Recherche Médicale, UMR1138, Equipe labellisée Ligue Nationale Contre le Cancer, Paris, France.
Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Université Pierre et Marie Curie, Villejuif, France.

Valentina Sica (V)

Cell Biology and Metabolomics Platforms, Gustave Roussy Cancer Center, Villejuif, France.
Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France.
Institut National de la Santé et de la Recherche Médicale, UMR1138, Equipe labellisée Ligue Nationale Contre le Cancer, Paris, France.
Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Université Pierre et Marie Curie, Villejuif, France.

José Manuel Bravo-San Pedro (JM)

Cell Biology and Metabolomics Platforms, Gustave Roussy Cancer Center, Villejuif, France.
Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France.
Institut National de la Santé et de la Recherche Médicale, UMR1138, Equipe labellisée Ligue Nationale Contre le Cancer, Paris, France.
Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Université Pierre et Marie Curie, Villejuif, France.

Sylvie Souquère (S)

AMMICA UMS-3655, Gustave Roussy Cancer Center, Villejuif, France.

Gérard Pierron (G)

CNRS, UMR9196, Villejuif, France.

Sylvie Lachkar (S)

Cell Biology and Metabolomics Platforms, Gustave Roussy Cancer Center, Villejuif, France.
Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France.
Institut National de la Santé et de la Recherche Médicale, UMR1138, Equipe labellisée Ligue Nationale Contre le Cancer, Paris, France.
Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Université Pierre et Marie Curie, Villejuif, France.

Allan Sauvat (A)

Cell Biology and Metabolomics Platforms, Gustave Roussy Cancer Center, Villejuif, France.
Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France.
Institut National de la Santé et de la Recherche Médicale, UMR1138, Equipe labellisée Ligue Nationale Contre le Cancer, Paris, France.
Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Université Pierre et Marie Curie, Villejuif, France.

Adriana Petrazzuolo (A)

Cell Biology and Metabolomics Platforms, Gustave Roussy Cancer Center, Villejuif, France.
Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France.
Institut National de la Santé et de la Recherche Médicale, UMR1138, Equipe labellisée Ligue Nationale Contre le Cancer, Paris, France.
Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Université Pierre et Marie Curie, Villejuif, France.

Ana Joaquina Jimenez (AJ)

Institut Curie, PSL Research University, CNRS UMR144, Paris, France.

Franck Perez (F)

Institut Curie, PSL Research University, CNRS UMR144, Paris, France.

Maria Chiara Maiuri (MC)

Cell Biology and Metabolomics Platforms, Gustave Roussy Cancer Center, Villejuif, France.
Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France.
Institut National de la Santé et de la Recherche Médicale, UMR1138, Equipe labellisée Ligue Nationale Contre le Cancer, Paris, France.
Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Université Pierre et Marie Curie, Villejuif, France.

Oliver Kepp (O)

Cell Biology and Metabolomics Platforms, Gustave Roussy Cancer Center, Villejuif, France. captain.olsen@gmail.com.
Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. captain.olsen@gmail.com.
Institut National de la Santé et de la Recherche Médicale, UMR1138, Equipe labellisée Ligue Nationale Contre le Cancer, Paris, France. captain.olsen@gmail.com.
Université Paris Descartes, Sorbonne Paris Cité, Paris, France. captain.olsen@gmail.com.
Université Pierre et Marie Curie, Villejuif, France. captain.olsen@gmail.com.

Guido Kroemer (G)

Cell Biology and Metabolomics Platforms, Gustave Roussy Cancer Center, Villejuif, France. kroemer@orange.fr.
Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. kroemer@orange.fr.
Institut National de la Santé et de la Recherche Médicale, UMR1138, Equipe labellisée Ligue Nationale Contre le Cancer, Paris, France. kroemer@orange.fr.
Université Paris Descartes, Sorbonne Paris Cité, Paris, France. kroemer@orange.fr.
Université Pierre et Marie Curie, Villejuif, France. kroemer@orange.fr.
Suzhou Institute for Systems Medicine, Chinese Academy of Sciences, Suzhou, China. kroemer@orange.fr.
Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. kroemer@orange.fr.
Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden. kroemer@orange.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH